Medicure (MCUJF) EPS (Diluted) Growth (3y) (2012 - 2026)
Medicure (MCUJF) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 50.12% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.26% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -70.43% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.24% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.96% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.19% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -18.62% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -51.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.42% |
| Dec 31, 2025 | -55.25% |
| Sep 30, 2025 | -36.35% |
| Jun 30, 2025 | -44.09% |
| Mar 31, 2025 | 15.18% |
| Sep 30, 2024 | 30.85% |
| Jun 30, 2024 | -60.63% |
| Mar 31, 2024 | -64.46% |
| Dec 31, 2023 | 45.41% |
| Sep 30, 2023 | 27.69% |
| Jun 30, 2023 | 143.32% |
| Mar 31, 2023 | 29.88% |
| Dec 31, 2022 | 35.49% |
| Sep 30, 2022 | 100.56% |
| Jun 30, 2022 | 46.97% |
| Mar 31, 2022 | 30.08% |
| Sep 30, 2021 | -91.67% |
| Jun 30, 2021 | -0.73% |
| Mar 31, 2021 | 16.21% |
| Dec 31, 2020 | -32.93% |